Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Vandana Singh

4606 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Aptinyx’s Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study

By Vandana Singh
August 12, 9:32 AM
Aptinyx Inc (NASDAQ: APTX) has announced results from a Phase 2b study evaluating the effects of NYX-2925 in patients with fibromyalgia, characterized by muscular or musculoskeletal pain with stiffness and localized tenderness at specific points.

APTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

UNITY Biotech Shares More Than Double On Positive Drug Data For Diabetes Associated Vision Loss

By Vandana Singh
August 12, 9:18 AM
UNITY Biotechnology Inc (NASDAQ:UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for…

UBX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Johnson & Johnson To Stop Selling Talc-Based Powder

By Vandana Singh
August 12, 7:48 AM
Johnson & Johnson (NYSE:JNJ) said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move amid…

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder

By Vandana Singh
August 12, 7:46 AM
Homology Medicines Inc (NASDAQ: FIXX) announced the details of HMI-204, its optimized, in vivo, one-time gene therapy candidate for metachromatic leukodystrophy (MLD). 

FIXX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Trading Ideas

This Nasal Spray For Eye Disease Stock Is ‘Attractive’, Has Potential 160% Upside

By Vandana Singh
August 11, 3:11 PM
Chardan initiated coverage on Oyster Point Pharma Inc (NASDAQ:OYST) with a Buy rating and a price target of $22. The lead product,…

ABBV

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Health Care
  • News
  • Penny Stocks
  • Price Target

Despite Competition This Analyst Finds BrainsWay Attractive

By Vandana Singh
August 11, 2:50 PM
Yesterday BrainsWay Ltd (NASDAQ:BWAY) reported Q2 sales of $8.0 million, up 14% Y/Y, missing the consensus of $8.47 million, amid a…

BWAY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing

By Vandana Singh
August 11, 2:48 PM
ProQR Therapeutics N.V. (NASDAQ:PRQR) said it would look for a partner to take the company’s ophthalmology portfolio further into clinical trials. …

LLY

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • News
  • Penny Stocks

Allena Pharma Needs To Raise Capital To Continue As A Going Concern

By Vandana Singh
August 11, 2:47 PM
Allena Pharmaceuticals Inc (NASDAQ:ALNA) says it lacks the financial resources to conduct studies for ALLN-346 for hyperuricemia and gout in the…

ALNA

Read More
1 minute read
  • Exclusives
  • General
  • Market-Moving Exclusives
  • News
  • Penny Stocks
  • Tech

EXCLUSIVE: ‘Creator-Economy’ Vocal App Comes to iOS, Enabling Wider Token Economics For Brands

By Vandana Singh
August 11, 1:43 PM
Creatd Inc (NASDAQ: CRTD) has announced the release of the Vocal mobile app for iOS to the general public. 

CRTD

Read More
2 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • Health Care
  • Legal
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke

By Vandana Singh
August 11, 11:40 AM
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

GSK

Posts pagination

Previous 1 … 434 435 436 … 461 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service